Cantex Pharmaceuticals' Series A Round

Cantex Pharmaceuticals raised a round of funding on August 15, 2002.

Cantex, formerly Paringenix, is a clinical stage biopharmaceutical company focused on developing and commercializing proprietary compounds that enhance the efficacy and safety of the treatment of canc…

Articles about Cantex Pharmaceuticals' Series A Round: